These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 25205664

  • 1. Asymptomatic Leishmania infections in northern India: a threat for the elimination programme?
    Das S, Matlashewski G, Bhunia GS, Kesari S, Das P.
    Trans R Soc Trop Med Hyg; 2014 Nov; 108(11):679-84. PubMed ID: 25205664
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Longitudinal Study of Transmission in Households with Visceral Leishmaniasis, Asymptomatic Infections and PKDL in Highly Endemic Villages in Bihar, India.
    Das VN, Pandey RN, Siddiqui NA, Chapman LA, Kumar V, Pandey K, Matlashewski G, Das P.
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005196. PubMed ID: 27974858
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP, Picado A, Alam S, Hasker E, Singh SP, Ostyn B, Chappuis F, Sundar S, Boelaert M.
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [Abstract] [Full Text] [Related]

  • 10. Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study.
    Ostyn B, Gidwani K, Khanal B, Picado A, Chappuis F, Singh SP, Rijal S, Sundar S, Boelaert M.
    PLoS Negl Trop Dis; 2011 Oct; 5(10):e1284. PubMed ID: 21991397
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Feasibility of eliminating visceral leishmaniasis from the Indian subcontinent: explorations with a set of deterministic age-structured transmission models.
    Le Rutte EA, Coffeng LE, Bontje DM, Hasker EC, Postigo JA, Argaw D, Boelaert MC, De Vlas SJ.
    Parasit Vectors; 2016 Jan 19; 9():24. PubMed ID: 26787302
    [Abstract] [Full Text] [Related]

  • 17. Visceral leishmaniasis elimination targets in India, strategies for preventing resurgence.
    Sundar S, Singh OP, Chakravarty J.
    Expert Rev Anti Infect Ther; 2018 Nov 19; 16(11):805-812. PubMed ID: 30289007
    [Abstract] [Full Text] [Related]

  • 18. Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent - A Systematic Literature Review.
    Hirve S, Boelaert M, Matlashewski G, Mondal D, Arana B, Kroeger A, Olliaro P.
    PLoS Negl Trop Dis; 2016 Aug 19; 10(8):e0004896. PubMed ID: 27490264
    [Abstract] [Full Text] [Related]

  • 19. Visceral leishmaniasis in southeastern Nepal: a cross-sectional survey on Leishmania donovani infection and its risk factors.
    Schenkel K, Rijal S, Koirala S, Koirala S, Vanlerberghe V, Van der Stuyft P, Gramiccia M, Boelaert M.
    Trop Med Int Health; 2006 Dec 19; 11(12):1792-9. PubMed ID: 17176343
    [Abstract] [Full Text] [Related]

  • 20. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis.
    Singh R, Kumar D, Ramesh V, Negi NS, Singh S, Salotra P.
    J Infect Dis; 2006 Aug 01; 194(3):302-6. PubMed ID: 16826477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.